Human Longevity Makes Clinical-Grade Whole Genome Sequencing Available to All for $599

The same genomic technology once limited to specialist programs is now accessible to anyone, paired with an AI platform built on over a decade of clinical data and a new multimillion-dollar collaboration with Insilico Medicine to predict disease before it begins.

SAN FRANCISCO, Aug. 4, 2026 /PRNewswire/ -- Human Longevity, Inc. (HLI), a precision health and longevity technology company, today announced the availability of Genomics for All, a clinical-grade whole genome sequencing product priced at $599. The offering sequences all 6.4 billion base pairs of an individual's DNA and delivers AI-interpreted results through the HLI app, with no clinic visit required.

Unlike consumer ancestry tests, which analyse less than 0.02% of the genome using SNP chip technology, Genomics for All sequences the entire genome at 30x clinical-grade depth, the coverage standard required for medically meaningful interpretation. The result is a fundamentally different class of information: one capable of identifying inherited disease risk across more than 10,000 genetic variants, flagging pharmacogenomic markers that affect how individuals respond to common medications including statins and GLP-1 receptor agonists, and screening for carrier status in hereditary conditions. The report also covers health-related traits across nutrition, metabolism, and exercise response.

A central feature of the product is its AI-powered re-analysis capability. Because the genome itself does not change, HLI re-analyses each client's genomic data on an ongoing basis as new research is published, new disease-gene associations are identified, and clinical guidelines are updated. When a new clinically relevant finding emerges, HLI proactively alerts affected clients, often within 24 hours of publication. This transforms a one-time sequencing event into a continuously evolving health resource.

"Our founder Dr. Venter helped make it possible for humanity to read the human genome," said Wei-Wu He, Ph.D., Chairman and CEO of Human Longevity. "With Genomics for All, we are continuing that vision by helping more people understand what their genome may mean for their long-term health. Our goal is not to replace physicians or make deterministic predictions, but to provide better information that can support more informed conversations, earlier awareness, and more personalised care."

Genomics for All sits within a broader AI-driven platform that HLI has been building for over a decade. In May 2026, HLI announced the launch of Human Life Foundation Models, Inc. (HLFM), a dedicated AI entity developed in partnership with Insilico Medicine, a clinical-stage generative AI biotechnology company. The multimillion-dollar collaboration aims to develop what the companies describe as the industry's first large-scale AI foundation model dedicated to longevity science, drawing on HLI's multimodal clinical and genomic datasets collected across more than 10,000 clients to identify the biological mechanisms of aging and enable predictive healthcare.

Genomics for All is the entry-level offering in HLI's broader suite of precision health programs, which also includes more comprehensive assessments combining advanced imaging, biomarker panels, and clinician-guided care. The scientific advisory board includes Nobel laureates Dr. Geoffrey Hinton and Dr. Michael Levitt.

Genomics for All is available now at humanlongevity.com/genomics for $599.

About Human Longevity, Inc.
Human Longevity, Inc. is a precision health company focused on helping individuals better understand and manage long-term health through genomics, AI-supported interpretation, advanced diagnostics, and clinician-guided care. Founded in 2013 by Dr. J. Craig Venter and other life sciences leaders, the company has invested approximately $600M in research and worked with more than 10,000 clients across its clinics in San Diego and San Francisco. HLI's programs include Genomics for All, Executive Health, 100+ Care, and 100+ Concierge. For more information, visit www.humanlongevity.com.

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Human Longevity Makes Clinical-Grade Whole Genome Sequencing Available to All for $599

Brand's largest brick-and-mortar expansion to date brings roadside emergency power off Amazon and onto Walmart shelves nationwide

SAN FRANCISCO, California, Aug. 4, 2026 /PRNewswire/ -- GOOLOO, a global leader in portable power and roadside safety solutions, today announced the in-store launch of three of its best-selling jump starters — the GOOLOO A3X, GOOLOO G7X, and GOOLOO GE1500X — now available at approximately 4,000 Walmart stores across the United States. The rollout marks GOOLOO's largest brick-and-mortar expansion to date, bringing the brand's roadside emergency technology from online marketplaces directly to shoppers nationwide.

"Nearly half of the more than 32 million roadside assistance calls AAA receives each year involve dead batteries, flat tires, or lockouts. We wanted these three jump starters within arm's reach of shoppers, not a shipping label away," said Michael, General Manager at GOOLOO.

Until now, GOOLOO's jump starters have been sold primarily through e-commerce channels. Their arrival at Walmart gives U.S. drivers same-day access to emergency power products, addressing a common frustration among customers who need battery assistance immediately rather than waiting on shipping.

The three products now available at Walmart include:

GOOLOO A3X 3000A Jump Starter with Air Compressor 

Designed as an all-in-one roadside solution, the A3X combines emergency jump-starting capability with a built-in tire inflator, helping drivers handle two of the most common roadside situations: dead batteries and low tire pressure.

Featuring automatic shut-off inflation, emergency lighting, USB power functionality, and GOOLOO's SUPERSAFE™ protection system with multiple layers of battery safety protection, the A3X provides drivers with confidence and convenience in one compact device.

GOOLOO G7X 3000A Jump Starter 

The G7X introduces a new approach to everyday jump starter design by combining emergency starting capability with portable charging convenience.

Its integrated USB-C 45W fast-charging cable serves as both a built-in charging solution and a compact carry design feature, allowing users to charge smartphones, including the latest USB-C devices, and select laptops.

By increasing everyday usability beyond emergency situations, the G7X transforms the traditional jump starter from a product stored away for occasional emergencies into a practical portable power companion.

GOOLOO GE1500X 1500A Jump Starter

Designed for everyday drivers, the GE1500X delivers reliable emergency starting power with a compact and easy-to-use design.

Featuring emergency lighting, USB power functionality, and advanced safety protections, the GE1500X provides dependable roadside support for daily driving needs.

The GE1500X offers 1500A peak current for vehicles up to 6.0L gas or 4.0L diesel engines, a 400-lumen emergency flashlight with SOS mode, and UL 2743 / c-TUV-us certified safety protections.

All three jump starters are available now at Walmart stores nationwide and on Walmart.com, in addition to GOOLOO's existing online retail channels.

About GOOLOO

GOOLOO is a leading global automotive roadside safety ecosystem brand specializing in high-performance lithium-ion portable jump starters, tire inflators, and multi-functional emergency tools. With its patented technologies SUPERSAFE®, JUMPCORE™ and TOOLCORE™, it has been serving millions of customers and drivers for over 12 years.

 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

GOOLOO Expands National Retail Footprint, Launches Three Top-Selling Jump Starters in Walmart stores across the country